These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 9422063)
1. [p53 as a molecular target for cancer therapy]. Ishioka C; Osada M; Gamo M; Kanamaru R Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063 [TBL] [Abstract][Full Text] [Related]
2. p53 tumor-suppressor gene: clues to molecular carcinogenesis. Wang XW; Harris CC J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531 [TBL] [Abstract][Full Text] [Related]
3. [TP53 mutations and molecular epidemiology]. Otsuka K; Ishioka C Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437 [TBL] [Abstract][Full Text] [Related]
5. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy. Wiman KG Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Selivanova G; Wiman KG Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433 [TBL] [Abstract][Full Text] [Related]
7. P53 tumor suppressor gene therapy for cancer. Nielsen LL; Maneval DC Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967 [TBL] [Abstract][Full Text] [Related]
8. Exploiting the p53 pathway for the diagnosis and therapy of human cancer. Lane DP Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788 [TBL] [Abstract][Full Text] [Related]
9. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy. Wang XW; Harris CC Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035 [TBL] [Abstract][Full Text] [Related]
10. p53: balancing tumour suppression and implications for the clinic. Buganim Y; Rotter V Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621 [TBL] [Abstract][Full Text] [Related]
11. The p53 tumour suppressor gene. Steele RJ; Thompson AM; Hall PA; Lane DP Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903 [TBL] [Abstract][Full Text] [Related]
12. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy]. Müller P; Nenutil R; Vojtĕsek B Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766 [TBL] [Abstract][Full Text] [Related]
13. p53 mutation heterogeneity in cancer. Soussi T; Lozano G Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939 [TBL] [Abstract][Full Text] [Related]
14. Transcription regulation by mutant p53. Weisz L; Oren M; Rotter V Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429 [TBL] [Abstract][Full Text] [Related]
15. p53: prospects for cancer gene therapy. Soddu S; Sacchi A Cytokines Cell Mol Ther; 1998 Sep; 4(3):177-85. PubMed ID: 9825843 [TBL] [Abstract][Full Text] [Related]
16. p53--a natural cancer killer: structural insights and therapeutic concepts. Römer L; Klein C; Dehner A; Kessler H; Buchner J Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711 [TBL] [Abstract][Full Text] [Related]
18. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332 [TBL] [Abstract][Full Text] [Related]
19. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer]. Fujiwara T; Inoue F; Tanaka N Gan To Kagaku Ryoho; 1998 Jan; 25(2):194-200. PubMed ID: 9474928 [TBL] [Abstract][Full Text] [Related]
20. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death]. Mendoza-Rodríguez CA; Cerbón MA Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]